DE69911427T2 - Komprimierte zusammensetzungen mit geklärter xanthangummi - Google Patents

Komprimierte zusammensetzungen mit geklärter xanthangummi Download PDF

Info

Publication number
DE69911427T2
DE69911427T2 DE69911427T DE69911427T DE69911427T2 DE 69911427 T2 DE69911427 T2 DE 69911427T2 DE 69911427 T DE69911427 T DE 69911427T DE 69911427 T DE69911427 T DE 69911427T DE 69911427 T2 DE69911427 T2 DE 69911427T2
Authority
DE
Germany
Prior art keywords
xanthan gum
release
active ingredient
weight
ibuprofen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69911427T
Other languages
German (de)
English (en)
Other versions
DE69911427D1 (de
Inventor
Maureen Nottingham DIXEY
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Reckitt Benckiser Healthcare UK Ltd
Original Assignee
Boots Co PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co PLC filed Critical Boots Co PLC
Application granted granted Critical
Publication of DE69911427D1 publication Critical patent/DE69911427D1/de
Publication of DE69911427T2 publication Critical patent/DE69911427T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69911427T 1998-08-01 1999-07-28 Komprimierte zusammensetzungen mit geklärter xanthangummi Expired - Fee Related DE69911427T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9816723.2A GB9816723D0 (en) 1998-08-01 1998-08-01 Therapeutic agents
GB9816723 1998-08-01
PCT/EP1999/005499 WO2000007569A1 (en) 1998-08-01 1999-07-28 Compressed compositions comprising clarified xanthan gum

Publications (2)

Publication Number Publication Date
DE69911427D1 DE69911427D1 (de) 2003-10-23
DE69911427T2 true DE69911427T2 (de) 2004-07-01

Family

ID=10836508

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69911427T Expired - Fee Related DE69911427T2 (de) 1998-08-01 1999-07-28 Komprimierte zusammensetzungen mit geklärter xanthangummi

Country Status (16)

Country Link
EP (1) EP1100471B1 (https=)
JP (1) JP2002522376A (https=)
CN (1) CN1160060C (https=)
AR (1) AR019981A1 (https=)
AT (1) ATE249815T1 (https=)
AU (1) AU744483B2 (https=)
CA (1) CA2339190C (https=)
DE (1) DE69911427T2 (https=)
DK (1) DK1100471T3 (https=)
ES (1) ES2207274T3 (https=)
GB (1) GB9816723D0 (https=)
MX (1) MXPA01000992A (https=)
NZ (1) NZ509593A (https=)
PT (1) PT1100471E (https=)
WO (1) WO2000007569A1 (https=)
ZA (1) ZA200100828B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1610551A (zh) 2001-07-06 2005-04-27 恩德制药公司 用作止痛剂的6－羟基羟吗啡酮的肠胃外给药
AU2002337686B2 (en) * 2001-09-26 2008-05-15 Penwest Pharmaceuticals Company Opioid formulations having reduced potential for abuse
CN117752805B (zh) * 2023-12-25 2024-12-24 山东聊城阿华制药股份有限公司 一种药用辅料及其制备方法
KR102881485B1 (ko) * 2024-03-22 2025-11-05 (주) 팜젠사이언스 천연첨가제에 기반한 비타민c 조성물 및 이를 포함하는 지속성 비타민c 정제

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4135979A (en) * 1976-08-24 1979-01-23 Merck & Co., Inc. Treatment of xanthan gum to improve clarity
GB8601204D0 (en) * 1986-01-18 1986-02-19 Boots Co Plc Therapeutic agents
US4915948A (en) * 1987-08-31 1990-04-10 Warner-Lambert Company Tablets having improved bioadhesion to mucous membranes
CA2017249C (en) * 1989-05-24 2000-07-25 Theresa M. Ortega Rheology controlled fabric printing composition and method

Also Published As

Publication number Publication date
DK1100471T3 (da) 2004-01-12
CN1160060C (zh) 2004-08-04
CA2339190C (en) 2008-11-18
CN1354653A (zh) 2002-06-19
ES2207274T3 (es) 2004-05-16
ATE249815T1 (de) 2003-10-15
DE69911427D1 (de) 2003-10-23
EP1100471A1 (en) 2001-05-23
EP1100471B1 (en) 2003-09-17
AR019981A1 (es) 2002-03-27
ZA200100828B (en) 2001-10-22
MXPA01000992A (es) 2002-06-04
AU5508799A (en) 2000-02-28
JP2002522376A (ja) 2002-07-23
NZ509593A (en) 2002-12-20
CA2339190A1 (en) 2000-02-17
AU744483B2 (en) 2002-02-28
PT1100471E (pt) 2003-12-31
GB9816723D0 (en) 1998-09-30
WO2000007569A1 (en) 2000-02-17

Similar Documents

Publication Publication Date Title
DE3779933T2 (de) Xanthangummienthaltende arzneimittelformulierung mit verzoegerter freisetzung.
DE3880762T2 (de) Orale, acetaminophen enthaltende zusammensetzung mit gesteuerter arzneistoff-freisetzung und verfahren zu ihrer herstellung.
DE69528204T2 (de) Tabletten enthaltend Amoxicillin und Clavulanate, die mit einem Polymerüberzug versehen sind
DE69315257T2 (de) Simethicon enthaltende Arzneimittel zur Behandlung gastrointestinaler Störungen
DE69802543T3 (de) Verbesserte multipartikel-tablette mit schnellauflösbarkeit
DE69826290T2 (de) Pharmazeutische zusammensetzungen zur kontrollierten freigabe von wirkstoffen
DE69230112T2 (de) Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin
DE69924381T2 (de) Leicht zerfallende feste zubereitung
DE69620606T2 (de) Feste oral anzuwendende arzeneiform
DE69727000T2 (de) Arzneimittel mit verzögerter Wirkstoffabgabe enthaltend Venlafaxin
DE60133538T2 (de) Formulierung und tabletten mit guaifenesin mit verzögerter freisetzung
DE69714739T2 (de) Arzneimittel mit verzögerter freisetzung, das ein dibenzothiazepinderivat enthält
DE69934505T2 (de) Im munde zerfallende tablette enthaltend ein benzimidazole
DE69727922T2 (de) Schnell zerfallende orale dosierungsform
DE60120413T2 (de) Quervernetzte stark amylose haltige stärke zur verwendung in pharmazeutischen formulierungen mit kontrollierter freisetzung und verfahren zu ihrer herstellung
DE3329265C2 (https=)
CH655241A5 (de) Verfahren zur herstellung therapeutisch wirksamer praeparate mit anhaltendem verlauf der wirkstoff-freisetzung.
DE69530759T2 (de) Filmbeschichtete tablette, die paracetamol und domperidone enthält
DE69814850T2 (de) Paracetamol enthaltende schlickbare tablette
DE112011101605T5 (de) Pharmazeutische Zusammensetzung umfassend Hydromorphon und Naloxon
EP0250648A2 (de) Pharmazeutisches Präparat zur verzögerten Freigabe von Ibuprofen
EP2863896B1 (de) Arzneiform zur freisetzung von wirkstoffen
EP3943071B1 (de) Zusammensetzung, enthaltend natürliche lipophile verbindungen, verwendung der zusammensetzung und verfahren zur herstellung der zusammensetzung
DE60320039T2 (de) Tramadol-formulierungen mit verzögerter freisetzung und 24-stunden-wirksamkeit
DE69911427T2 (de) Komprimierte zusammensetzungen mit geklärter xanthangummi

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: RECKITT BENCKISER HEALTHCARE INTERNATIONAL LTD, GB

8327 Change in the person/name/address of the patent owner

Owner name: RECKITT BENCKISER HEALTHCARE (UK) LTD., SLOUGH, GB

8339 Ceased/non-payment of the annual fee